Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Target-Oriented Strategy of Ultra-Low LDL-C Goal in Extreme-High-Risk ASCVD Patients
NCT07615296Not yet recruiting
- Sponsor
- Beijing An Zhen Hospital
- Start
- Jan 2027
- Primary completion
- Dec 2029
- Countries
- 1
01
Overview
Randomised, open-label trial in atherosclerotic cardiovascular disease (ASCVD) (2 arms), sponsored by Beijing An Zhen Hospital. Primary endpoint: Major Adverse Cardiovascular Events-4 up to 5 years. Planned start Jan 2027; status: not yet recruiting.
02
Conditions
atherosclerotic cardiovascular disease (ASCVD)
Beyond the preview
Go deeper on NCT07615296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07615296.